Novo Nordisk deepens Aspect Biosystems alliance in push for curative diabetes cell therapies
Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
The study evaluated patients with stage III/IV melanoma after complete tumor resection
The new investment will fuel expansion of Avalon's Diagnostic Intelligence capabilities
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
Over 8.8?million Indians aged 60 and above currently live with dementia,
India in the Changing Landscape of Life-Sciences Research & Development
The AI Nurse Companion, designed as a language-first learning platform, allows students to gain real-world German language proficiency through immersive practice
The BEAR Implant is the first sports medicine device to carry a label claim related to lowering PTOA risk
Favorable outcome would contribute to significantly containing the Roundup litigation as the company continues its multi-pronged strategy
Subscribe To Our Newsletter & Stay Updated